3E Bioventures
Status
INACTIVE
Global HQ
China
Countries of investment
- Portugal
Investment stages
- Seed
Industries
About
3E Bioventures is a venture Capital firm based in Beijing, China, specializing in growth Capital. The firm focuses on the healthcare sector, investing in early and late stage ventures within drug development, medical devices, diagnostics, healthcare IT, and medical services. Founded in 2015 by Karen Liu, 3E Bioventures leverages its team's deep biomedical expertise and extensive industry experience to identify and nurture promising healthcare startups in China and overseas. The firm manages both RMB and US Dollar funds, reflecting its commitment to global investment opportunities.,
3E Bioventures is a venture Capital firm based in Beijing, China, specializing in growth Capital. The firm focuses on the healthcare sector, investing in early and late stage ventures within drug development, medical devices, diagnostics, healthcare IT, and medical services. Founded in 2015 by Karen Liu, 3E Bioventures leverages its team's deep biomedical expertise and extensive industry experience to identify and nurture promising healthcare startups in China and overseas. The firm manages both RMB and US Dollar funds, reflecting its commitment to global investment opportunities.,
Investment Thesis
3E Bioventures is dedicated to Capitalizing on the significant growth potential in the Chinese healthcare industry over the next 10 to 20 years. The firm aims to leverage its team's biomedical Training and healthcare industry experience to support early and growth stage companies. By combining a global industry perspective with practical ontheground experience in China, 3E Bioventures seeks to build successful healthcare ventures and technologies that generate substantial returns for investors. The firm is committed to fostering innovation in the healthcare sector and establishing itself as a leading international healthcare investment brand.,
Portfolio
Rapafusyn Pharmaceuticals
Cellbri
Arnatar Therapeutics
Tianhu Technology
varnotech
Myrobalan Therapeutics
Jushu Biotech
Smartlens
Novlead Biotech
Eaglenos
Dermaliq Therapeutics
Cardea Bio
Lipidio Pharmaceuticals
Ansun BioPharma
Profusa
C4 Therapeutics
Cytek Biosciences
Biocytogen
MicuRx Pharmaceuticals
Apexigen
OncoImmune